Skip to content
Riskpilot
← Back to search
Sign in
Get full access
XelBio AB
AB
Active
Org 5592131303
Djursholm
Business and other management consultancy activities
· NACE 7020
Est. 2019
1 employees
Watchlist
Share
Sweden
/
Companies
/
Business and other management consultancy activities
/
XelBio AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 033
237
0
0
237
Staff expenses
—
—
−10
−10
−10
EBITDA
171
−42
−78
−100
151
Depreciation & amort.
−6
−6
−6
−6
−0
EBIT
165
−48
−85
−106
−85
Net financials
1
−1
5
4
0
Profit before tax
164
6
−15
−102
−85
Tax
−40
−6
—
—
—
Net profit
124
0
−15
−102
−85
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
994
473
279
180
106
Equity
463
276
261
159
74
Long-term debt
0
0
—
—
—
Short-term debt
411
132
18
22
32
Total debt
411
132
18
22
32
Financial ratios
5-year trend
EBITDA margin
64.0%
This company
15.8%
Market median
+305% vs market
2021
2025
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
2021
2025
Return on equity
-114.8%
This company
18.4%
Market median
-724% vs market
2021
2025
Net profit margin
-35.8%
This company
8.1%
Market median
-542% vs market
2021
2025
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
2021
2025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on XelBio AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network